This demonstrates that IL-1β is a downstream mediator of IL-6 and IL-10 and its regulation is crucial as part of the signaling mechanisms to achieve the beneficial effects of IL-6 in non-steatotic grafts and IL-10 in steatotic ones when both are subjected to BD+LT. Here, IL10 is linked to Behcet disease.